发明名称 MEDICINE COMPOSITION
摘要 PROBLEM TO BE SOLVED: To obtain a medicine composition capable of exhibiting excellent effects, reducing a dose and alleviating adverse effect, comprising a compound having angiotensin II antagonism and a compound having an action mechanism except that of angiotensin II antagonism. SOLUTION: This medicine is obtained by combining a compound of the formula (R<1> is H or a substitutable hydrocarbon residue; R<2> is carboxyl which can be esterified; R<3> is an anion forming group, etc.; X is phenylene directly bonded to phenylene or bonded through phenylene; (n) is 1 or 2; the ring A is as shown for R<2> or a benzene ring which may be substituted; Y is a direct bond, O, etc.) having angiotensin II antagonism or its salt as an active ingredient with at least one of a compound having enhancing action on insulin sensitivity, a compound having improving action on hyperglycemia of diabetic after meal, an indane derivative having inhibitory action on an enzyme capable of converting angiotensin, a pyridine derivative having inhibitory action on HMG- GoA reductase and their salts. The medicine is effective useful for arterial hypertension as a complication of arteriosclerosis and hypertension.
申请公布号 JPH09323940(A) 申请公布日期 1997.12.16
申请号 JP19970086484 申请日期 1997.04.04
申请人 TAKEDA CHEM IND LTD 发明人 TAMURA NORIKAZU;SODA TAKASHI;IKEDA HITOSHI
分类号 A61K31/4184;A61K31/133;A61K31/41;A61K31/415;A61K31/425;A61K31/44;A61K38/04;A61K45/06;A61P3/06;A61P3/08;A61P3/10;A61P7/02;A61P9/00;A61P9/08;A61P9/10;A61P9/12;A61P13/02;A61P15/00;A61P17/00;A61P25/18;A61P25/20;A61P25/24;A61P25/26;A61P25/28;A61P27/02;A61P43/00;C07D403/10;C07D413/10;C07D413/14;C07D417/10;(IPC1-7):A61K45/06 主分类号 A61K31/4184
代理机构 代理人
主权项
地址